| KDP |
Report |
Adjusted diluted EPS |
IN-LINE |
pred ~$0.580 vs. cons $0.575 |
MEDIUM |
| KDP |
Report |
Total revenue |
IN-LINE |
pred ~$7.30B vs. cons $7.245B |
MEDIUM |
| KDP |
Report |
U.S. Coffee operating income |
BEAT |
pred ~$260M vs. cons $253.8M |
MEDIUM |
| KDP |
Guide |
FY26 net sales |
UNCHANGED |
guide ~$25.9B-$26.4B vs. cons $26.264B |
MEDIUM |
| KDP |
Guide |
FY26 CC adjusted EPS growth |
UNCHANGED |
guide ~low double-digit growth vs. reported EPS cons $2.439; comparability UNVERIFIED |
LOW |
| KDP |
Guide |
H2 coffee / EPS trajectory |
UNCHANGED |
guide ~sequential coffee improvement and H2 acceleration; consensus UNVERIFIED |
LOW |
| KDP |
Return |
Day-1 residual (stock − beta × S&P 500) |
-1.5% |
— |
LOW |
| KDP |
Return |
5-day cumulative residual |
-2.5% (FOLLOW-THROUGH) |
FOLLOW-THROUGH — Archetype F lacks a forward-estimate catalyst |
LOW |